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Summary A study of 361 female melanoma patients and age matched controls was conducted in the four
western provinces of Canada. Analysis of reproductive factors showed a significant negative association
between number of livebirths and risk of melanoma. The relationship persisted for superficial spreading
melanomas after adjustment for host pigmentation factors, freckling, and educational status. An inverse
association between bilateral oophorectomy and risk of superficial spreading melanoma was also seen. No
association was found between risk of melanoma and age at first birth, age at menarche and age at natural
menopause. No association was found between risk of superficial spreading or nodular melanoma and use of
either oral contraceptives or menopausal oestrogens.
Several studies have examined the putative
relationship between use of exogenous estrogens
and risk of malignant melanoma. Holly et al. (1983)
found women using oral contraceptives for 5 or
more years have an elevated risk of superficial
spreading melanomas. Adam et al. (1981) found a
suggestion of increased risk of melanoma in British
women using oral contraceptives for more than 5
years, although the increase was not statistically
significant. A further study of California women
(Beral et al., 1977) found a higher rate of
melanoma in women who used oral contraceptives;
most pronounced in women with more than 4 years
duration of use. Beral et al. (1984) found an
elevated risk of melanoma in women who used oral
contraceptives for 5 years or more beginning at
least 10 years prior to diagnosis of the tumour.
A number of other studies however have found
no consistent association between use of oral
contraceptives and risk of melanoma (Bain et al.,
1982; Kay, 1981; Helmrich et al., 1983) including
the recent large Australian study by Holman et al.
(1984).
Several of the previous studies also reviewed a
variety of reproductive factors including age at first
birth, number of livebirths and age at menopause,
and Holly et al. (1983) found an elevated risk of
superficial spreading melanoma in women with a
late age at first birth. No other studies have
reported significant findings.
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We have conducted a population-based case
control of malignant melanoma in Western Canada
and this report details our findings on exogenous
hormones and reproductive factors in relation to
nielanoma risk.
Methods
All histologically confirmed cases of melanoma
newly diagnosed in the 4 western provinces of
Canada (British Columbia, Alberta, Saskatchewan,
Manitoba) were ascertained for the period April 1,
1979 through March 31, 1981 from the provincial
cancer registries. Complete details of the subjects,
our interview document, and methods of data
collection have been described in our previous
report (Elwood et al., 1984).
In the 2 year period, 904 patients with newly
diagnosed primary cutaneous melanoma were
registered. Four hundred and sixty two were
females and comprise the caseload for the present
report. Of these 462 cases, 412 were age-eligible for
interview (age 20-79). Three hundred and sixty one
(88%) were interviewed. Of the female cases not
interviewed, 5 died before interview, and 14 could
not be located. In a further 6 cases, their physicians
felt that an interview would not be in the best
interest of the patient, and a further 26 of the
potential subjects refused interview.
Controls were selected at random from provincial
microfiche listing of medical insurance plan
subscribers which include virtually the entire adult
population of each province. In Alberta,
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Saskatchewan and Manitoba, our study co-
ordinators were allowed access to medical plan
listings, and subjects selected were telephoned to
request co-operation; 59% of those contacted
agreed to participate. In British Columbia a letter
requesting participation was sent out to each
selected subject by the Medical Services
Commission and individuals had to send back a
completed consent form; no telephone contact was
permitted. This gave us a control reponse rate of
48% in B.C.
Information was obtained by personal home
interview, on reproductive history, and use of oral
contraceptives and other oestrogens. In addition,
host pigmentation factors were assessed.
Colour of skin was determined by direct
comparison with prosthesis samples made for the
project. Colour was evaluated twice on both a sun
exposed area (dorsum of hands), and a non-sun
exposed area (upper inner arms). Hair colour was
evaluated using a direct comparison with wig
makers samples. In the event that hair colour had
greyed with age, subjects were asked to indicate
their natural hair colour in childhood and as a
young adult. Information on sensitivity to sunlight,
adolescent freckling and exposure to sunlight
during occupational, recreational and vacation
pursuits (by decade of life) was also collected.
Crude associations between cutaneous melanoma,
reproductive factors, use of oral contraceptives and
use of other exogenous oestrogens were first
evaluated using matched pair odds ratios as an
estimate of relative risk. To adjust for significant
host and pigmentation variables (hair colour, skin
colour, freckling in adolescence) and educational
status, which might confound analysis of the
reproductive and oral contraceptive variables, a
matched pairs multiple logistic model was fitted
using procedures specified by Breslow and Day
(1980).
Results
Of the total of 361 interviewed cases, 269 were
superficial spreading, 66 were nodular and 26 were
unclassified melanomas. Lentigo malignas were not
included in this analysis. For purposes of analysis
all 361 melanomas were analysed as a group, and
superficial spreading and nodular cases were then
examined separately. There were not enough
unclassified melanomas to analyse separately.
Cases and controls did not differ significantly in
respect to marital status (Table I), however cases
had a higher educational attainment than did
controls.
Degree of obesity was measured in subjects using
Quetelet's index calculated from subjects' weight at
Table I Demographic factors and malignant melanoma:
361 female melanomas and matched controls
Factor Category Cases % Controls % RR'
Marital status Ever married 93 94 1.0
Never married 8 6 1.2
X2=0.2, P=n.s.
Education 11y 28 37 1.0
12-13y 17 16 1.7
14+ 55 48 1.8
x2 (trend) =9.4, P=0.009
Quetellet's 20 23 20 1.0
Index 21-24 48 43 1.0
25-29 18 25 0.6
30+ 11 11 0.8
x2 (trend)= 5.5, P= n.s.
'RR based on matched pairs and P values for trend.
interview. Quetelet's Index is a measure of body
mass, calculated by dividing the subject's weight in
kilograms by the square of her height in metres. No
statistically significant differences were seen for all
melanomas or for superficial spreading and nodular
melanomas when the subtypes were analysed
separately. Subjects had also been questioned about
body weight in their teens and also 5 years prior to
interview. No association was seen with risk of
melanoma for Quetelet's indices calculated for these
periods.
Because of the possibility of risk of melanoma
being related to endogenous hormonal factors, the
data was analysed for age at first birth and
numbers of livebirths; variables which are
important in the aetiology of other hormone related
tumours such as breast and ovarian cancer (Brinton
et al., 1979; Kelsey et al., 1982; Hildreth et al.,
1981). Univariate analysis demonstrated a
significant negative association between risk of
melanoma and number of live births (Table II),
which persisted for superficial spreading melanomas
even after adjustment for host factors, educational
status and age at first birth. Although the trend for
nodular melanomas was similar to that of
superficial spreading lesions, the association was
not statistically significant for this histologic
subtype. The initial weak association between age
at first birth and risk of melanoma disappeared
after adjusting for number of livebirths.
Because of the relatively low reponse rate among
controls we were concerned that women in our
control group may have had a parity history
atypical of the Western Canadian female
population. Data was obtained from the 1981
Canadian Census by 5 year age group on ever
married Western Canadian women having 0, 1, 2,
3, 4 and 5+ livebirths. Proportions of ever marriedREPRODUCTIVE FACTORS AND MELANOMA RISK 903
Table II Parity factors and risk of malignant melanoma
All melanomas (361) S.S. melanomas (269) Nodular melanomas (66)
% RR RR % RR RR % RR RR
Factor Category Cases Crude Adjusteda Cases Crude Adjusteda Cases Crude Adjusteda
No. oflive 0 20 1.0 1.0 20 1.0 1.0 17 1.0 1.0
births 1-2 42 1.0 1.0 43 0.9 1.0 44 1.4 0.7
3-4 31 0.8 0.8 31 0.7 0.8 29 0.8 2.9
5+ 7 0.3 0.3 6 0.3 0.4 11 0.3 0.6
x2 =5.2 X2 =5-5 %2 =2.4
P =0.02 P =0.02 P=n.s
Age at <24y 45 1.0 1.0 43 1.0 1.0 52 1.0 1.0
first birth 25-29y 22 1.1 0.9 22 1.0 0.9 23 2.0 2.1
30+ y
or never 33 1.4 1.1 34 1.4 0.9 26 1.4 2.6
x2=1.4 x2=O.l x2=3.6
P=n.s. P=n.s. P=n.s.
aFor no. of livebirths, each RR adjusted for skin colour, hair colour, freckling, educational status and age at birth by
matched logistic analysis; For age at first birth, each RR adjusted for skin colour, hair colour, freckling, educational status
and no. of livebirths by matched logistic analysis.
women with 0, 1-2, 3-4, and 5+ livebirths in our
control group were compared with the Western
Canadian population after weighting for differences
in age structure between the 2 groups of women.
Results showed that our control group was quite
representative of Western Canadian women for
number ofliveborn children (Table III).
Table Ill Parity in ever married cutaneous melanoma
controls and ever married Western Canadian Female
populationa
No. Western Canada
livebirths Controls (%) female population (%)
0 15.5 15.0
1-2 43.3 45.0
3-4 28.5 25.6
5+ 12.7 14.4
Total 100.0 100.0
aEver married controls include 339 women or 94% of
controls used in the study.
Several other reproductive factors were examined
including age at menarche, age at natural
menopause and bilateral oophorectomy (Table IV).
No association was seen for age at menopause. For
age at menarche, no association was seen for
superficial spreading melanomas. A significantly
elevated risk of nodular melanoma in women
having menarche at a late age was seen, however,
the elevated risk was relatively small after
adjustment for host factors and educational status.
Women with prior bilateral oophorectomy
appeared to have a significantly lowered risk of
melanoma. When melanoma subtypes were
examined the association persisted for superficial
spreading melanoma. The trend for nodular
melanoma appeared to be the reverse of that for
superficial spreading lesions, however the risk
estimate for nodular lesions was not statistically
significant and was based on only 9 cases with
bilateral oophorectomy.
Oral contraceptive use was examined in female
cases and controls, age 20-69 (Table V). Subjects
age 70-79 were excluded because these women
would have reached menopause prior to the
introduction of oral contraceptives to the market
place. No association was seen with the risk of
melanoma. A further analysis controlling for
number of livebirths showed no association.
Separate analyses were performed for women age
20-39 and 40-69, and demonstrated no relationship
between use of oral contraceptives and risk of
melanoma.
In view of the fact that a recent study by Beral et
al. (1984) demonstrated a significant association
with melanoma only in women who had used oral
contraceptives at least 10 years prior to diagnosis,
we reviewed data on years since last oral
contraceptive use. No association was seen with
years since last use (Trend=0.068, P=n.s.), even in
women who had previously used oral contraceptives
10 more years prior to diagnosis (RR= 1.0). Other904 R.P. GALLAGHER et al.
Table IV Other reproductive factors and risk of malignant melanoma
All melanomas (361) S.S. melanomas (269) Nodular melanomas (66)
% RR RR % RR RR % RR RR
Factor Category Cases Crude Adjusteda Cases Crude Adjusteda Cases Crude Adjusteda
Age at
menarche
Age at natural
menopause
<13y
13-14y
15+ y
<45y
49-49y
50-53y
54+ y
Otherb
35
50
16
5
9
11
5
70
1.0
1.2
1.0
1.0
1.2
1.2
1.2
1.3
1.0
1.3
1.2
x2= 1.2
P=n.s.
1.0
1.3
0.8
1.0
0.9
x2= 1.3
P=n.s
43
22
34
6
9
10
5
69
1.0
1.0
1.4
1.0
1.4
0.9
0.9
1.1
1.0
1.1
1.1
XP =0.3
P=n.s.
1.0
1.6
0.6
0.8
0.7
X=5.5
P=n.s.
52
23
26
<50
50+16
Other 74
1.0
2.0
1.4
1.0
1.2
1.3
x2 =4.0
P=0.05
1.0
3.2
2.4
1.0
1.4
2.1
x2=1.0
P=n.s.
Bilateral No
Oophorectomy Yes
92 1.0 1.0
8 0.6 0.5
X2=5.5
P=0.02
94 1.0 1.0
6 0.4 0.3
x2= 10.6
P=0.001
aEach RR adjusted for skin colour, hair colour, freckling and educational status by logistic analysis; bOther includes
premenopausal women and women with surgical or radiation induced menopause; cNodular melanoma categories= <50,
50+, Other due to small numbers of cases.
Table V Oral contraceptives and risk ofmalignant melanoma
All melanomas (333) S.S. melanomas (250) Nodular melanomas (59)
% RR RR % RR RR % RR RR
Factor Category Cases Crude Adjusteda Cases Crude Adjusteda Cases Crude Adjusteda
Oral Not used 42 1.0 1.0 44 1.0 1.0 42 1.0 1.0
contraceptive < I y 10 1.1 1.0 10 1.0 1.1 15 1.9 1.5
useb 1-4y 23 1.0 0.9 21 0.9 1.1 31 1.3 1.0
5+ y 23 0.9 0.8 25 1.0 0.9 12 0.8 0.3
X2 = 1.6 X2= .5 %2=2.2
P=n.s. P=n.s. P=n.s.
aBased on 333 cases age 20-69 at diagnosis and their matched controls; bEach RR adjusted for skin colour, hair colour,
freckling and educational status by matched logistic analysis.
exogenous oestrogen use (mainly menopausal
oestrogens) was not associated with either elevated
or reduced risk of subsequent melanoma (Table
VI). Analysis by histologic subtype showed no
association with superficial spreading or nodular
lesions for either oral contraceptives or menopausal
oestrogens.
Discussion
The recent controversy in the epidemiologic
literature regarding melanoma and hormonal
factors in females has centred on the use by women
of exogenous preparations, viz oral contraceptives
and menopausal oestrogens. To date, the evidence
concerning these compounds has been divided, with
several studies demonstrating an effect from oral
contraceptives, and other studies showing no effect.
Our study results show no relationship between
the use of oral contraceptives and risk of mela-
noma. Likewise no association was demonstrated
with menopausal oestrogens. The results from the
Western Canada Melanoma Study did, however,
86 1.0
14 1.3
1.0
1.6
x2=0.5
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Table VI Other exogeneous oestrogen use and risk ofmalignant melanoma
All melanomas (361) S.S. melanomas (269) Nodular melanomas (59)
% RR RR % RR RR % RR RR
Factor Category Cases Crude Adjusteda Cases Crude Adjusteda Cases Crude Adjusteda
Other Not used 75 1.0 1.0 76 1.0 1.0 82 1.0 1.0
Oestrogen use <1 y 9 1.1 1.0 9 1.0 1.0 5 0.9 0.7
1-4y 8 0.9 1.0 7 0.8 1.0 9 0.6 0.5
5+ y 8 1.1 0.9 8 1.1 0.9 4 0.7 0.9
X2=0.1 X2=0.1 X2 0.4
P=n.s. P=n.s. P=n.s.
aEach RR adjusted for skin colour, hair colour, freckling and educational status, by matched logistic analysis.
show several interesting statistically significant
associations between risk of melanoma and
endogenous hormonal and reproductive factors.
The most important of these is the inverse
relationship between number of livebirths and
superficial spreading melanoma.
Because of the relatively low response rate among
controls we investigated the possibility that our
control subjects were atypical of the population of
Western Canadian women in respect to livebirths.
If women in our control group had selectively
agreed to interview because they happened to be at
home with children rather than being employed in
the work force, our perceived relationship could
well have been due to distortion of relative risks
brought about by control sampling bias.
Comparison of our controls with census figures for
Western Canada, however, showed this not to be
the case.
Female cases in our study were of higher
educational status than controls, and hence are
thought to be of higher socio-economic status. It is
known that women of higher socio-economic status
tend to have lower parity. We attempted to control
for socio-economic status in our multivariate
analyses by including educational status in the
model. The only way in which socio-economic
status could have confounded our analysis and in
fact been responsible for the finding of inverse
relationship between risk of melanoma and parity,
is if educational status in our women was not a
good indicator of true socio-economic status.
The other interesting finding is the suggestion
that prior oophorectomy may reduce risk of
subsequent superficial spreading melanoma. The
only other study which examined this factor found
no association with melanoma (Holly et al.. 1983).
The question as to whether pregnancy and
childbirth may influence the survival of patients
with melanoma has been a topic of interest for
some years, and several studies have found that
pregnancies before diagnosis are conducive to a
relatively favourable prognosis in melanoma (Shaw
et al., 1978, Hersey et al., 1977). However, an equal
or greater number have found no difference, or a
worse survival in women with prior pregnancies
(Elwood & Coldman, 1978; Weiss & Flannery,
1978; Lee & Hill, 1970). While the relationship of
pregnancy factors with melanoma is presently
unclear, to our knowledge no studies to date have
found reproductive events to be risk factors in the
aetiology of melanoma, with the exception of Holly
et al. (1983).
It is of interest to note that the associations seen
in our study with number of pregnancies and
bilateral oophorectomy are similar to those seen
with breast cancer. In addition there is some
evidence that initial diagnosis of either breast
cancer or melanoma may put a subject at higher
risk for the other tumour (Schoenberg & Christine,
1980; Vaisman et al., 1979). Many investigations
have demonstrated that nulliparous women are at
higher risk of breast cancer than parous women
(Blot, 1980, Miller et al., 1980, MacMahon et al.,
1970), however, there does not appear to be much
of an increase in protection afforded by multiple
births after the first full term birth (MacMahon et
al., 1970). It should be noted however that the
increased risk in low parity women with breast
cancer is, in most studies, completely explained by
the womens' late age at first birth. This appears not
to be the case with our melanoma patients, Our
melanoma data indicates that pregnancy does not
become protective until a woman has had 3 or
more children. Of interest is the fact that Holly et
al. (1983) found a relative risk of 0.65 for
superficial spreading melanoma in women having 5
or more children. In addition Holman et al. (1984)
demonstrated a relative risk of 0.73 for melanoma
in women having 5+ children. These lowered
relative risks may perhaps be supportive of our
finding of a somewhat lowered rate of melanoma in
women with many children.
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oophorectomy and lowered risk of superficial
spreading melanoma is similar to that seen in breast
cancer (Feinleib, 1968; Kelsey et al., 1981). Our
findings for nodular melanoma show a different
trend but are based on small numbers of cases and
the association is not statistically significant.
In conclusion, while it is recognised that
oestrogen receptors are present in a proportion of
human melanomas (Creagan et al., 1980; Fisher et
al., 1976; Posey et al., 1977), most investigative
work in the field of epidemiology has focused on
exogenous hormonal preparations such as oral
contraceptives and menopausal oestrogens. Our
findings suggest that if hormonal variables influence
risk of melanoma in women it may be that the
factors are endogenous rather than exogenous.
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